Key Research Areas Studied for selective agonism at GLP-1 for metabolic and weight loss effects
Recent studies and case reports indicate that the weight loss drug may cause serious health risks, including gastroparesis
There is no race consistency matters more than intensity
GLP-1 research compounds are typically supplied as a lyophilized powder in sealed laboratory vials
Younger adults may be more comfortable with convenience-led healthcare, digital prescribing and treatments that fit more naturally into everyday life, helping tablets feel more approachable than injections
In the past few years, there has been increased interest in employing cannabis-based products as therapeutics, simultaneously with an increase in the flexibility in laws and regulations regarding the personal use of cannabis [8,9,10]